FDA
-
-
-
-
-
-
-
Better Therapeutics Signs Rebate Agreement with One of the Largest Pharmacy Benefit Managers in the US for its AspyreRx Diabetes Treatment
-
-
-
-
-
-
-
Better Therapeutics (BTTX) Strengthens Financial Position Through Amendment to Debt Facility and Implementation of Cost Reductions
-
-
-
-
-
-
-
Better Therapeutics Announces Launch of AspyreRxTM to Treat Adults with Type 2 Diabetes
-
-
-
-
-
-
-
Better Therapeutics to Release Second Quarter 2023 Financial Results and Provide Business Update on August 09, 2023
-
-
-
-
-
-
-
Better Therapeutics to Release First Quarter 2023 Financial Results and Provide Business Update on May 11, 2023
-
-
-
-
-
-
-
Better Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
-
-
-
-
-
-
Positive Results from Pivotal Trial of Better Therapeutics’ Investigational BT-001 Prescription Digital Therapy for Type 2 Diabetes Published in Diabetes Care
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

